• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽类SARS-CoV主要蛋白酶抑制剂的结构特征:定量构效关系研究

Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.

作者信息

Masand Vijay H, Akasapu Siddhartha, Gandhi Ajaykumar, Rastija Vesna, Patil Meghshyam K

机构信息

Department of Chemistry, Vidya Bharati Mahavidyalaya, Amravati, Maharashtra, 444 602, India.

Corden Pharma, Colorado, USA.

出版信息

Chemometr Intell Lab Syst. 2020 Nov 15;206:104172. doi: 10.1016/j.chemolab.2020.104172. Epub 2020 Oct 3.

DOI:10.1016/j.chemolab.2020.104172
PMID:33518858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833253/
Abstract

In the present work, an extensive QSAR (Quantitative Structure Activity Relationships) analysis of a series of peptide-type SARS-CoV main protease (MPro) inhibitors following the OECD guidelines has been accomplished. The analysis was aimed to identify salient and concealed structural features that govern the MPro inhibitory activity of peptide-type compounds. The QSAR analysis is based on a dataset of sixty-two peptide-type compounds which resulted in the generation of statistically robust and highly predictive multiple models. All the developed models were validated extensively and satisfy the threshold values for many statistical parameters (for e.g. R ​= ​0.80-0.82, Q  ​= ​0.74-0.77,  ​= ​0.66-0.67). The developed QSAR models identified number of sp hybridized Oxygen atoms within seven bonds from aromatic Carbon atoms, the presence of Carbon and Nitrogen atoms at a topological distance of 3 and other interrelations of atom pairs as important pharmacophoric features. Hence, the present QSAR models have a good balance of Qualitative (Descriptive QSARs) and Quantitative (Predictive QSARs) approaches, therefore useful for future modifications of peptide-type compounds for anti- SARS-CoV activity.

摘要

在本研究中,按照经合组织指南对一系列肽类严重急性呼吸综合征冠状病毒主蛋白酶(MPro)抑制剂进行了广泛的定量构效关系(QSAR)分析。该分析旨在确定决定肽类化合物MPro抑制活性的显著和潜在结构特征。QSAR分析基于一个包含62种肽类化合物的数据集,由此生成了具有统计学稳健性和高度预测性的多个模型。所有开发的模型都经过了广泛验证,并满足许多统计参数的阈值(例如,R = 0.80 - 0.82,Q = 0.74 - 0.77, = 0.66 - 0.67)。所开发的QSAR模型确定了与芳香族碳原子在七个键内的sp杂化氧原子数量、拓扑距离为3处的碳和氮原子的存在以及其他原子对的相互关系作为重要的药效团特征。因此,目前的QSAR模型在定性(描述性QSAR)和定量(预测性QSAR)方法之间取得了良好的平衡,因此对于未来肽类化合物抗SARS-CoV活性的修饰很有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/155473309bf5/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/d2ba747c0470/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/7c282b5767e6/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/d71ee60760b4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/2dc27200fabf/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/363c2dd7dea2/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/51f7b7a8d78d/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/83bb92919cae/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/155473309bf5/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/d2ba747c0470/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/7c282b5767e6/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/d71ee60760b4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/2dc27200fabf/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/363c2dd7dea2/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/51f7b7a8d78d/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/83bb92919cae/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55f0/7833253/155473309bf5/gr8_lrg.jpg

相似文献

1
Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.肽类SARS-CoV主要蛋白酶抑制剂的结构特征:定量构效关系研究
Chemometr Intell Lab Syst. 2020 Nov 15;206:104172. doi: 10.1016/j.chemolab.2020.104172. Epub 2020 Oct 3.
2
Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.利用基于定量构效关系的虚拟筛选、分子对接、分子动力学模拟和分子力学广义 Born 表面面积方法鉴定有效的醛糖还原酶抑制剂作为抗糖尿病(降血糖)药物。
Saudi Pharm J. 2022 Jun;30(6):693-710. doi: 10.1016/j.jsps.2022.04.003. Epub 2022 Apr 7.
3
Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.使用 QSAR 建模技术扩展鉴定具有抗 SARS-CoV 活性的肽类化合物的结构特征。
SAR QSAR Environ Res. 2020 Sep;31(9):643-654. doi: 10.1080/1062936X.2020.1784271. Epub 2020 Aug 27.
4
Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis.基于定量构效关系的虚拟筛选、分子对接和分子动力学模拟分析从食物中鉴定抗SARS-CoV-2化合物
Pharmaceuticals (Basel). 2021 Apr 13;14(4):357. doi: 10.3390/ph14040357.
5
Quantitative Structure-Activity Relationship Evaluation of MDA-MB-231 Cell Anti-Proliferative Leads.MDA-MB-231 细胞抗增殖先导物的定量构效关系评价。
Molecules. 2021 Aug 7;26(16):4795. doi: 10.3390/molecules26164795.
6
QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods.使用量子化学描述符和统计方法对不对称芳族二硫化物作为强效禽源SARS-CoV主要蛋白酶抑制剂进行定量构效关系研究。
Chemometr Intell Lab Syst. 2021 Mar 15;210:104266. doi: 10.1016/j.chemolab.2021.104266. Epub 2021 Feb 3.
7
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.利用定量构效关系建模、分子对接和分子动力学模拟设计靶向严重急性呼吸综合征冠状病毒2主要蛋白酶的强效抑制剂
Pharmaceuticals (Basel). 2023 Apr 18;16(4):608. doi: 10.3390/ph16040608.
8
QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.定量构效关系评估揭示赖氨酸特异性组蛋白去甲基化酶 1A 抑制剂的结构特征,为新型抗癌先导化合物开发提供支持:基于分子对接、分子动力学模拟和 MMGBSA 的研究
Molecules. 2022 Jul 25;27(15):4758. doi: 10.3390/molecules27154758.
9
QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human -Myristoyltransferase (Hs-NMT) Inhibitors.氮杂环作为有效的人酰基转移酶(Hs-NMT)抑制剂的定量构效关系和药效团建模。
Molecules. 2021 Mar 24;26(7):1834. doi: 10.3390/molecules26071834.
10
Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease.结合对接、分子动力学模拟、AD-MET药代动力学性质和MMGBSA计算,创建专门的方案,以便对自身免疫性疾病和SARS-CoV-2主要蛋白酶开展有效的虚拟筛选活动。
Front Mol Biosci. 2023 Sep 1;10:1254230. doi: 10.3389/fmolb.2023.1254230. eCollection 2023.

引用本文的文献

1
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.基于方法的 SARS-CoV-2 分子建模、模拟和预测综述。
Chem Rev. 2022 Jul 13;122(13):11287-11368. doi: 10.1021/acs.chemrev.1c00965. Epub 2022 May 20.
2
Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations.利用分子对接和分子动力学模拟鉴定食品化合物作为新型冠状病毒主要蛋白酶的抑制剂
Chemometr Intell Lab Syst. 2021 Oct 15;217:104394. doi: 10.1016/j.chemolab.2021.104394. Epub 2021 Jul 22.
3
Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis.

本文引用的文献

1
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
2
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.新型冠状病毒肺炎及相关人类冠状病毒疾病治疗药物和疫苗的研发
ACS Cent Sci. 2020 Mar 25;6(3):315-331. doi: 10.1021/acscentsci.0c00272. Epub 2020 Mar 12.
3
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
基于定量构效关系的虚拟筛选、分子对接和分子动力学模拟分析从食物中鉴定抗SARS-CoV-2化合物
Pharmaceuticals (Basel). 2021 Apr 13;14(4):357. doi: 10.3390/ph14040357.
4
QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods.使用量子化学描述符和统计方法对不对称芳族二硫化物作为强效禽源SARS-CoV主要蛋白酶抑制剂进行定量构效关系研究。
Chemometr Intell Lab Syst. 2021 Mar 15;210:104266. doi: 10.1016/j.chemolab.2021.104266. Epub 2021 Feb 3.
基于网络的2019新型冠状病毒(2019-nCoV/SARS-CoV-2)药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
4
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.COVID-19,一种新兴的冠状病毒感染:在疫苗、免疫疗法和治疗药物的设计和开发方面的进展和前景。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238. doi: 10.1080/21645515.2020.1735227. Epub 2020 Mar 18.
5
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.α-酮酰胺作为冠状病毒和肠病毒复制的广谱抑制剂:基于结构的设计、合成和活性评估。
J Med Chem. 2020 May 14;63(9):4562-4578. doi: 10.1021/acs.jmedchem.9b01828. Epub 2020 Feb 24.
6
Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis.基于喹喔啉酮的醛糖还原酶抑制剂:2D 和 3D-QSAR 分析。
Mol Inform. 2019 Aug;38(8-9):e1800149. doi: 10.1002/minf.201800149. Epub 2019 May 27.
7
On the Misleading Use of for QSAR Model Comparison.用于 QSAR 模型比较的误导性使用。
Mol Inform. 2019 Jan;38(1-2):e1800029. doi: 10.1002/minf.201800029. Epub 2018 Aug 24.
8
QSAR Modeling is not "Push a Button and Find a Correlation": A Case Study of Toxicity of (Benzo-)triazoles on Algae.定量构效关系建模并非“一键操作并找到相关性”:以(苯并)三唑对藻类的毒性为例的研究
Mol Inform. 2012 Dec;31(11-12):817-35. doi: 10.1002/minf.201200075. Epub 2012 Nov 19.
9
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.严重急性呼吸综合征冠状病毒(SARS-CoV)3CL蛋白酶抑制剂概述:拟肽和小分子化疗药物
J Med Chem. 2016 Jul 28;59(14):6595-628. doi: 10.1021/acs.jmedchem.5b01461. Epub 2016 Feb 29.
10
Coronaviruses - drug discovery and therapeutic options.冠状病毒——药物研发与治疗选择
Nat Rev Drug Discov. 2016 May;15(5):327-47. doi: 10.1038/nrd.2015.37. Epub 2016 Feb 12.